WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jacqueline Elizabeth SheaChief Executive Officer2024-02-26872$8.16
$7.12kSell
Laurent HumeauChief Scientific Officer2024-02-26770$8.16
$6.28kSell
Peter KiesCFO2024-02-262,358$8.16
$19.24kSell
Peter KiesCFO2024-02-261,108$8.16
$9.04kSell
Laurent HumeauChief Scientific Officer2024-02-261,581$8.16
$12.90kSell
Jacqueline Elizabeth SheaChief Executive Officer2024-02-262,856$8.16
$23.30kSell
Lota S. ZothDirector2023-06-055,700$0.56
$3.19kSell
Jacqueline Elizabeth SheaChief Executive Officer2023-05-1028,704$0.81
$23.25kSell

1 of 1

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe88.36%20,650,987$227.78MInsider
Vanguard Group Inc84.58%19,766,062$218.02MInstitution
Renaissance Technologies LLC31.22%7,297,379$80.49MInstitution
Tee Khiang Ng20.97%4,899,931$54.05MInsider
Blackrock Inc16.83%3,932,564$43.38MInstitution
Gsa Capital Partners LLP16.25%3,796,529$41.88MInstitution
Geode Capital Management LLC12.29%2,871,445$31.67MInstitution
D E Shaw Co Inc11.56%2,701,162$29.79MInstitution
Jong Joseph Kim10.04%2,346,000$25.88MInsider
Jacobs Levy Equity Management Inc4.92%1,149,974$12.68MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO61.56%38.44%Net SellingNet Selling
TSVT65.20%34.80%Net BuyingNet Buying
PBYI55.20%44.43%Net Selling
STRO78.85%21.15%Net SellingNet Selling
ADAP7.28%92.72%Net SellingNet Selling

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 214.70% institutional shareholders, 134.08% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 88.36% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $226.95M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.